Dr Penny Hartmann
Dr Penny Hartmann
Dr Penny Hartmann first joined the Murdoch Children’s Research Institute in 2010, after completing her undergraduate studies in psychology at the University of Adelaide. She completed her PhD at Monash University in 2017, investigating the early development of children who were exposed to antiepileptic medication in utero. Her research experience ranges from studies investigating the development of young children, especially those requiring surgery in infancy, through to those investigating brain changes in older adults. Penny has a special interest in child neurodevelopment, as well as parental/familial experiences within the healthcare setting.
Dr Penny Hartmann first joined the Murdoch Children’s Research Institute in 2010, after completing her undergraduate studies in psychology at the University of Adelaide. She completed her PhD at Monash University in 2017, investigating the early...
Dr Penny Hartmann first joined the Murdoch Children’s Research Institute in 2010, after completing her undergraduate studies in psychology at the University of Adelaide. She completed her PhD at Monash University in 2017, investigating the early development of children who were exposed to antiepileptic medication in utero. Her research experience ranges from studies investigating the development of young children, especially those requiring surgery in infancy, through to those investigating brain changes in older adults. Penny has a special interest in child neurodevelopment, as well as parental/familial experiences within the healthcare setting.
Top Publications
- Crowe, LM, Clarke, C, Hearps, S, Pugh, R, Kilpatrick, N, Branson, E, Payne, JM, Haebich, KM, McCloughan, N, Kintakas, C, et al. Mental health impacts of the COVID-19 pandemic on children and adolescents with chronic health conditions. 2024 view publication
- McCann, ME, de Graaff, JC, Dorris, L, Disma, N, Withington, D, Bell, G, Grobler, A, Stargatt, R, Hunt, RW, Sheppard, SJ, et al. Neurodevelopmental outcome at 5 years of age after general anaesthesia or awake-regional anaesthesia in infancy (GAS): an international, multicentre, randomised, controlled equivalence trial.. Lancet 393(10172) : 664 -677 2019 view publication
- Davidson, AJ, Disma, N, de Graaff, JC, Withington, DE, Dorris, L, Bell, G, Stargatt, R, Bellinger, DC, Schuster, T, Arnup, SJ, et al. Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): an international multicentre, randomised controlled trial.. Lancet 387(10015) : 239 -250 2016 view publication
Career information
Share //
